The Food and Drug Administration said Monday it will quickly analyze any vaccine booster shots against Covid-19 variants such as those from South Africa and the U.K., and won’t require further large clinical trials of the new shots’ effectiveness.
Trending:
FDA looks to quickly authorize COVID-19 vaccine booster shots as new variants emerge